CN104069438A - Traditional Chinese medicine composition for treating hyperplasia of mammary glands - Google Patents
Traditional Chinese medicine composition for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN104069438A CN104069438A CN201410323097.XA CN201410323097A CN104069438A CN 104069438 A CN104069438 A CN 104069438A CN 201410323097 A CN201410323097 A CN 201410323097A CN 104069438 A CN104069438 A CN 104069438A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating hyperplasia of mammary glands. The traditional Chinese medicine comprises the following medicinal materials: radix bupleuri, Paris polyphylla, muskroot-like semiaquilegia root, Circium japonicum, Akebia Fruit, pericarpium citri reticulatae viride, bighead atractylodes rhizome, curcuma aromatica, the carda part of radix angelicae sinensis, Isodon amethystoides, dandelion and buddleia. The traditional Chinese medicine composition for treating hyperplasia of mammary glands is reasonable in raw material composition, simple in preparation process, low in price and convenient to take, is easily accepted by patients, does not have a toxic or side effect and is good in effect of treating the hyperplasia of mammary glands.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy is women's commonly encountered diseases, frequently-occurring disease, and its sickness rate has reached the more than 4% of the women of child-bearing age, accounts for 75% of whole cystic hyperplasia of breast.Cyclomastopathy is divided into gland cyclomastopathy, capsule cyclomastopathy, fibroid cyclomastopathy by pathomorphology, and wherein gland cyclomastopathy ranks first.Primary disease be one easily examine, refractory, the easy disease of recurrence.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of cyclomastopathy.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of cyclomastopathy, the material that it comprises following weight proportioning: Radix Bupleuri 8-12 part, Rhizoma Paridis 8-12 part, Radix Semiaquilegiae 8-12 part, Radix Cirsii Japonici 8-12 part, Fructus Akebiae 8-12 part, Pericarpium Citri Reticulatae Viride 8-12 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Radix Curcumae 8-12 part, Radix Angelicae Sinensis 8-12 part, Herba Rabdosiae glaucocalycis (Labiatae Rabdosia plant Herba Rabdosiae glaucocalycis Rabdosia amethystoides (Benth.) Hara, is used as medicine with herb or root) 15-24 part, Herba Taraxaci 15-24 part, Herba Buddlejae Lindleyanae (Latin formal name used at school Buddleja lindleyana Fortune) 15-24 part, Retinervus Luffae Fructus 15-24 part, Spica Prunellae 10-15 part, Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 10-15 part, Fructus glochidionis puberi(Herba Glochidii Puberi) (Latin formal name used at school Glochidion puberum L) 10-15 part, Fructus Trichosanthis 10-15 part, Spina Gleditsiae 10-15 part, Concha Ostreae 10-15 part, Radix Paeoniae Rubra 10-15 part, Radix Trichosanthis 10-15 part, Semen Juglandis 20-30 part, Radix Glycyrrhizae 6-10 part, Corii Bovis seu Bubali freezes (for the herb of Maguireothamnus speciosus Herba Paederiae Poederia scandens (Lour.) Merr.) 8-15 part and Radix Rubiae rattan (Radix Rubiae rattan is the aerial parts of Maguireothamnus speciosus Radix Rubiae) 8-15 part.
Preferably, the material that the Chinese medicine composition for the treatment of cyclomastopathy of the present invention comprises following weight proportioning: 10 parts of Radix Bupleuri, 10 parts of Rhizoma Paridis, 10 parts of Radix Semiaquilegiaes, 10 parts of Radix Cirsii Japonicis, 10 parts of Fructus Akebiaes, 10 parts, Pericarpium Citri Reticulatae Viride, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Radix Curcumaes, 10 parts of Radix Angelicae Sinensis, 20 parts of Herba Rabdosiae glaucocalycis, 20 parts of Herba Taraxacis, 20 parts of Herba Buddlejae Lindleyanaes, 20 parts of Retinervus Luffae Fructuss, 12 parts of Spica Prunellaes, 12 parts of Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus)s, 12 parts of Fructus glochidionis puberi(Herba Glochidii Puberi)s, 12 parts of Fructus Trichosanthis, 12 parts of Spina Gleditsiaes, 12 parts of Concha Ostreaes, 12 parts of Radix Paeoniae Rubra, 13 parts of Radix Trichosanthis, 25 parts of Semen Juglandis, 8 parts of Radix Glycyrrhizae, Corii Bovis seu Bubali freezes 13 parts, 11 parts and Radix Rubiae rattan.
More preferably, the Chinese medicine composition for the treatment of cyclomastopathy of the present invention also comprises the material of following weight proportioning: 8 parts of Radix Saposhnikoviaes, 6 parts of Folium Artemisiae Argyis, 5 parts of Sanguis Draxonis, 7 parts, Flos Carthami, 6 parts of Caulis Loniceraes, 3 parts of Scolopendras, 5 parts of Folium Eriobotryaes, 7 parts of Radix Platycodoniss, 9 parts of Rhizoma Chuanxiongs, 7 parts of Pericarpium Citri Reticulataes, 5 parts of Herba Lycopodiis, 12 parts of Radix Angelicae Sinensis, 8 parts of Ramulus Cinnamomi, 12 parts of the Radixs Astragali, 5 parts of Herba Asaris, 12 parts of Fructus Chaenomeliss, 5 parts of Caulis Spatholobis, 6 parts of Bulbus Fritillariae Cirrhosae, 6 parts of Fructus Mumes, 3 parts of common mouse ear, 7 parts of Fructus Schisandrae Chinensis, 6 parts of Cortex Mori, 6 parts of Radix Ophiopogonis, 8 parts, Poria, 5 parts of Radix Rhodiolaes, 8 parts of Radix Arnebiae (Radix Lithospermi)s, 6 parts of 3 parts of Herba Ecliptaes and Flos Camelliae Japonicae.
More preferably, described Chinese medicine composition can be tablet, dispersible tablet, powder or ointment.
Rationally, preparation technology is simple for the Chinese medicine composition raw material composition for the treatment of cyclomastopathy of the present invention, and price is low, and taking convenience, easily for patient accepts.Have no side effect, treatment cyclomastopathy is effective, is a kind of comparatively desirable medicine of current cyclomastopathy treatment.
Detailed description of the invention
Embodiment 1:
Take 10 grams of Radix Bupleuri, 10 grams of Rhizoma Paridis, 10 grams of Radix Semiaquilegiaes, 10 grams of Radix Cirsii Japonicis, 10 grams of Fructus Akebiaes, 10 grams, Pericarpium Citri Reticulatae Viride, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Radix Curcumaes, 10 grams of Radix Angelicae Sinensis, 20 grams of Herba Rabdosiae glaucocalycis, 20 grams of Herba Taraxacis, 20 grams of Herba Buddlejae Lindleyanaes, 20 grams of Retinervus Luffae Fructuss, 12 grams of Spica Prunellaes, 12 grams of Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus)s, 12 grams of Fructus glochidionis puberi(Herba Glochidii Puberi)s, 12 grams of Fructus Trichosanthis, 12 grams of Spina Gleditsiaes, 12 grams of Concha Ostreaes, 12 grams of Radix Paeoniae Rubra, 13 grams of Radix Trichosanthis, 25 grams of Semen Juglandis, 8 grams of Radix Glycyrrhizae, Corii Bovis seu Bubali freezes 13 grams, 11 grams and Radix Rubiae rattan, pulverize, cross 100 mesh sieves, then add 250 grams, vaseline, mix homogeneously, divide and install in 100 pipe flexible pipes, obtain ointment 1.
Embodiment 2:
Take 10 grams of Radix Bupleuri, 10 grams of Rhizoma Paridis, 10 grams of Radix Semiaquilegiaes, 10 grams of Radix Cirsii Japonicis, 10 grams of Fructus Akebiaes, 10 grams, Pericarpium Citri Reticulatae Viride, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Radix Curcumaes, 10 grams of Radix Angelicae Sinensis, 20 grams of Herba Rabdosiae glaucocalycis, 20 grams of Herba Taraxacis, 20 grams of Herba Buddlejae Lindleyanaes, 20 grams of Retinervus Luffae Fructuss, 12 grams of Spica Prunellaes, 12 grams of Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus)s, 12 grams of Fructus glochidionis puberi(Herba Glochidii Puberi)s, 12 grams of Fructus Trichosanthis, 12 grams of Spina Gleditsiaes, 12 grams of Concha Ostreaes, 12 grams of Radix Paeoniae Rubra, 13 grams of Radix Trichosanthis, 25 grams of Semen Juglandis, 8 grams of Radix Glycyrrhizae, Corii Bovis seu Bubali freezes 11 grams, 13 grams, Radix Rubiae rattan, 8 grams of Radix Saposhnikoviaes, 6 grams of Folium Artemisiae Argyis, 5 grams of Sanguis Draxonis, 7 grams, Flos Carthami, 6 grams of Caulis Loniceraes, 3 grams of Scolopendras, 5 grams of Folium Eriobotryaes, 7 grams of Radix Platycodoniss, 9 grams of Rhizoma Chuanxiongs, 7 grams of Pericarpium Citri Reticulataes, 5 grams of Herba Lycopodiis, 12 grams of Radix Angelicae Sinensis, 8 grams of Ramulus Cinnamomi, 12 grams of the Radixs Astragali, 5 grams of Herba Asaris, 12 grams of Fructus Chaenomeliss, 5 grams of Caulis Spatholobis, 6 grams of Bulbus Fritillariae Cirrhosae, 6 grams of Fructus Mumes, 3 grams of common mouse ear, 7 grams of Fructus Schisandrae Chinensis, 6 grams of Cortex Mori, 6 grams of Radix Ophiopogonis, 8 grams, Poria, 5 grams of Radix Rhodiolaes, 8 grams of Radix Arnebiae (Radix Lithospermi)s, 6 grams of 3 grams of Herba Ecliptaes and Flos Camelliae Japonicae, pulverize, and crosses 100 mesh sieves, then adds 250 grams, vaseline, and mix homogeneously divides and installs in 100 pipe flexible pipes, obtains ointment 2.
Experimental example
All cases is 2012-2013 60 medical routine female patients.The oldest 49 years old, minimum 20 years old, average 32.6 years old, wherein unmarried woman's 36 examples, married 24 examples; The course of disease is the longest 6 years, the shortest March; One-sided pathological changes 32 examples, bilateral pathological changes 28 examples, the minimum 0.2cm × 5.1cm of hypertrophy enclosed mass, maximum 2.0cm × 5.1cm, wherein nodositas lump 28 examples, lamellar lump 32 examples.Clinical manifestation is lump in breast, and premenstrual distending pain increases the weight of, through after alleviate gradually, with menstrual cycle and feelings will change relevant, the symptom such as some patients were companion dysmenorrhea, menstrual period are delayed, two side of body distending pains.Have a medical check-up: breast one or both sides can touch that nodositas or lamellar lump, matter are tough, rough, obscure boundary Chu, have light tenderness.Make a definite diagnosis through mammary X-ray mammography in nonpalpable breast or mammary gland ultrasound diagnosis, get rid of other mastopathy such as breast carcinoma and fibroma, and the Patients of Mammary Gland Hyperplasia that had not used medicine or additive method to treat in 3 months.60 parts of cases meet nodules of the breast in " traditional Chinese medical science disease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine issues for 1994 diagnostic criteria (State Administration of Traditional Chinese Medicine. Chinese medical discrimination Standardization of diagnosis and curative effect [M]. Nanjing: the .1994:45-46 of publishing house of Nanjing University).Above-mentioned 60 routine patients are divided into treatment group 1 and 2, two groups of patients for the treatment of group at difference not statistically significant aspect age and the state of an illness (P > 0.05), there is comparability.
In treatment group 1 use embodiment 1, the ointment 1 of preparation is treated, and every day 2 times, uses 2 pipes at every turn, is evenly coated on breast.If one-sided pathological changes, 2 pipes are coated on one-sided breast.If bilateral pathological changes, 2 pipes are coated on bilateral breast.Treatment 2 months continuously.
In treatment group 2 use embodiment 2, the ointment 2 of preparation is treated, and every day 2 times, uses 2 pipes at every turn, is evenly coated on breast.If one-sided pathological changes, 2 pipes are coated on one-sided breast.If bilateral pathological changes, 2 pipes are coated on bilateral breast.Treatment 2 months continuously.
Criterion of therapeutical effect
Reference " traditional Chinese medical science disease Standardization of diagnosis and curative effect " (Huang Haofu. the Clinics and Practices [M] of ambulatory surgery disease. the 2nd edition. Guangzhou: Guangdong science tech publishing house, 2002:72-73) work out.Cure: lump in breast and pain disappear, and within after drug withdrawal 3 months, do not recur.Effective: lump in breast dwindles more than 1/2, pain disappears.Effective: lump in breast dwindles less than 1/2, pain relief.Invalid: the unchanged or simple mastalgia of lump in breast and pain is alleviated.
Result
The therapeutic outcome of two groups is as follows:
Treatment group 1: cure 9 examples, effective 11 examples, effective 9 examples, invalid 1 example;
Treatment group 2: cure 15 examples, effective 12 examples, effective 3 examples.
In treatment, observe, do not occur serious adverse reaction, blood, urine, stool routine and hepatic and renal function to two groups of patients in treatment check, are showed no abnormal.
Claims (4)
1. treat the Chinese medicine composition of cyclomastopathy for one kind, it is characterized in that the material that it comprises following weight proportioning: Radix Bupleuri 8-12 part, Rhizoma Paridis 8-12 part, Radix Semiaquilegiae 8-12 part, Radix Cirsii Japonici 8-12 part, Fructus Akebiae 8-12 part, Pericarpium Citri Reticulatae Viride 8-12 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Radix Curcumae 8-12 part, Radix Angelicae Sinensis 8-12 part, Herba Rabdosiae glaucocalycis 15-24 part, Herba Taraxaci 15-24 part, Herba Buddlejae Lindleyanae 15-24 part, Retinervus Luffae Fructus 15-24 part, Spica Prunellae 10-15 part, Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 10-15 part, Fructus glochidionis puberi(Herba Glochidii Puberi) 10-15 part, Fructus Trichosanthis 10-15 part, Spina Gleditsiae 10-15 part, Concha Ostreae 10-15 part, Radix Paeoniae Rubra 10-15 part, Radix Trichosanthis 10-15 part, Semen Juglandis 20-30 part, Radix Glycyrrhizae 6-10 part, Corii Bovis seu Bubali freezes 8-15 part and Radix Rubiae rattan 8-15 part.
2. the Chinese medicine composition for the treatment of cyclomastopathy according to claim 1, it is characterized in that the material that it comprises following weight proportioning: 10 parts of Radix Bupleuri, 10 parts of Rhizoma Paridis, 10 parts of Radix Semiaquilegiaes, 10 parts of Radix Cirsii Japonicis, 10 parts of Fructus Akebiaes, 10 parts, Pericarpium Citri Reticulatae Viride, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Radix Curcumaes, 10 parts of Radix Angelicae Sinensis, 20 parts of Herba Rabdosiae glaucocalycis, 20 parts of Herba Taraxacis, 20 parts of Herba Buddlejae Lindleyanaes, 20 parts of Retinervus Luffae Fructuss, 12 parts of Spica Prunellaes, 12 parts of Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus)s, 12 parts of Fructus glochidionis puberi(Herba Glochidii Puberi)s, 12 parts of Fructus Trichosanthis, 12 parts of Spina Gleditsiaes, 12 parts of Concha Ostreaes, 12 parts of Radix Paeoniae Rubra, 13 parts of Radix Trichosanthis, 25 parts of Semen Juglandis, 8 parts of Radix Glycyrrhizae, Corii Bovis seu Bubali freezes 13 parts, 11 parts and Radix Rubiae rattan.
3. the Chinese medicine composition for the treatment of cyclomastopathy according to claim 2, it is characterized in that it also comprises the material of following weight proportioning: 8 parts of Radix Saposhnikoviaes, 6 parts of Folium Artemisiae Argyis, 5 parts of Sanguis Draxonis, 7 parts, Flos Carthami, 6 parts of Caulis Loniceraes, 3 parts of Scolopendras, 5 parts of Folium Eriobotryaes, 7 parts of Radix Platycodoniss, 9 parts of Rhizoma Chuanxiongs, 7 parts of Pericarpium Citri Reticulataes, 5 parts of Herba Lycopodiis, 12 parts of Radix Angelicae Sinensis, 8 parts of Ramulus Cinnamomi, 12 parts of the Radixs Astragali, 5 parts of Herba Asaris, 12 parts of Fructus Chaenomeliss, 5 parts of Caulis Spatholobis, 6 parts of Bulbus Fritillariae Cirrhosae, 6 parts of Fructus Mumes, 3 parts of common mouse ear, 7 parts of Fructus Schisandrae Chinensis, 6 parts of Cortex Mori, 6 parts of Radix Ophiopogonis, 8 parts, Poria, 5 parts of Radix Rhodiolaes, 8 parts of Radix Arnebiae (Radix Lithospermi)s, 6 parts of 3 parts of Herba Ecliptaes and Flos Camelliae Japonicae.
4. according to the Chinese medicine composition of the treatment cyclomastopathy described in any one in claims 1 to 3, it is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, instant, buccal tablet, powder or ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410323097.XA CN104069438A (en) | 2014-07-09 | 2014-07-09 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410323097.XA CN104069438A (en) | 2014-07-09 | 2014-07-09 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104069438A true CN104069438A (en) | 2014-10-01 |
Family
ID=51591304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410323097.XA Pending CN104069438A (en) | 2014-07-09 | 2014-07-09 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104069438A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104605067A (en) * | 2014-12-31 | 2015-05-13 | 广州至信中药饮片有限公司 | Breast beautifying tea and preparation method of tea |
| CN105707993A (en) * | 2016-03-02 | 2016-06-29 | 宁波高新区苗姑养生科技有限公司 | Bras for preventing and treating female breast lobular hyperplasia |
| CN106770785A (en) * | 2017-01-11 | 2017-05-31 | 合肥华润神鹿药业有限公司 | A kind of method of the finger-print for setting up madder rattan medicinal material |
| CN106822790A (en) * | 2017-03-09 | 2017-06-13 | 顾平洋 | A kind of Chinese medicine composition for treating hyperplasia of mammary glands |
-
2014
- 2014-07-09 CN CN201410323097.XA patent/CN104069438A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104605067A (en) * | 2014-12-31 | 2015-05-13 | 广州至信中药饮片有限公司 | Breast beautifying tea and preparation method of tea |
| CN105707993A (en) * | 2016-03-02 | 2016-06-29 | 宁波高新区苗姑养生科技有限公司 | Bras for preventing and treating female breast lobular hyperplasia |
| CN106770785A (en) * | 2017-01-11 | 2017-05-31 | 合肥华润神鹿药业有限公司 | A kind of method of the finger-print for setting up madder rattan medicinal material |
| CN106770785B (en) * | 2017-01-11 | 2019-03-01 | 合肥华润神鹿药业有限公司 | A method of establishing the finger-print of madder rattan medicinal material |
| CN106822790A (en) * | 2017-03-09 | 2017-06-13 | 顾平洋 | A kind of Chinese medicine composition for treating hyperplasia of mammary glands |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463568B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101966320A (en) | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN103386086A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN105106852A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and breast cancer | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN104069438A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN102671141B (en) | Chinese medicine for curing hyperplasia of mammary glands | |
| CN105617151A (en) | Powder boiling type traditional Chinese medicine antibacterial and anti-inflammatory agent, preparation method and applications thereof | |
| CN102688387B (en) | Medicine for treating subacute thyroiditis | |
| CN103446376A (en) | Traditional Chinese medicine composition used for treating radiation proctitis | |
| CN102886031A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands and preparation method of traditional Chinese medicine | |
| CN103385999B (en) | Chinese medicine composition for treating acute mastitis | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103446350A (en) | Traditional Chinese medicine for treating chronic appendicitis | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN102885995B (en) | Traditional Chinese medicine for treating acute lymphadenitis | |
| CN102451378A (en) | Uterus health capsule for treating gynopathy | |
| CN104524477A (en) | Traditional Chinese medicine composition for treating nodular goiter | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN104258272A (en) | Traditional Chinese medicine for treating nodules of breast | |
| CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141001 |